Posizolid

N/A

Report date: 2022/05/18 12:09:13
NME

Base Information

Drug NamePosizolid
Drug Alias Nameposizolidum珀司唑烷泊西唑利德泼斯唑利AZD-5847 +[6] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Oxazolidinone antibioticsSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of Action50S ribosomal subunit inhibitorsProtein biosynthesis inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsTuberculosis, PulmonaryTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Africa
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Pharmaceutical Co LtdAstrazeneca PlcNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsTuberculosis, PulmonaryTuberculosis

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank